An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.
Elaine RutherfordGraham StewartJ Graeme HoustonAlan G JardinePatrick B MarkAllan D StruthersPublished in: Journal of clinical pharmacology (2017)
Keyphrases